
### [NCIT:C40076](http://purl.obolibrary.org/obo/NCIT_C40076)
**Label:** Ovarian Clear Cell Tumor

**Subclasses:** [NCIT:C40078](http://purl.obolibrary.org/obo/NCIT_C40078) (Ovarian Clear Cell Adenocarcinoma), [NCIT:C40079](http://purl.obolibrary.org/obo/NCIT_C40079) (Ovarian Clear Cell Adenocarcinofibroma), [NCIT:C40077](http://purl.obolibrary.org/obo/NCIT_C40077) (Malignant Ovarian Clear Cell Tumor), [NCIT:C40085](http://purl.obolibrary.org/obo/NCIT_C40085) (Ovarian Clear Cell Adenofibroma), [NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma), [NCIT:C40083](http://purl.obolibrary.org/obo/NCIT_C40083) (Borderline Ovarian Clear Cell Cystadenofibroma), [NCIT:C40084](http://purl.obolibrary.org/obo/NCIT_C40084) (Benign Ovarian Clear Cell Tumor), [NCIT:C40081](http://purl.obolibrary.org/obo/NCIT_C40081) (Borderline Ovarian Clear Cell Adenofibroma), [NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma), [NCIT:C40080](http://purl.obolibrary.org/obo/NCIT_C40080) (Borderline Ovarian Clear Cell Tumor), [NCIT:C7980](http://purl.obolibrary.org/obo/NCIT_C7980) (Ovarian Clear Cell Cystadenocarcinoma), 

**Class expressions from DL-Learner:**

- Thing 52.82%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) 39.52%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39899](http://purl.obolibrary.org/obo/NCIT_C39899) (Secondary Prostate Urothelial Carcinoma))) 39.52%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39897](http://purl.obolibrary.org/obo/NCIT_C39897) (Prostate Ductal Adenocarcinoma, Solid Pattern))) 39.52%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39896](http://purl.obolibrary.org/obo/NCIT_C39896) (Prostate Ductal Adenocarcinoma, Papillary Pattern))) 39.52%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39895](http://purl.obolibrary.org/obo/NCIT_C39895) (Prostate Ductal Adenocarcinoma, Cribriform Pattern))) 39.52%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C3989](http://purl.obolibrary.org/obo/NCIT_C3989) (Parathyroid Hyperplasia))) 39.52%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39885](http://purl.obolibrary.org/obo/NCIT_C39885) (Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant))) 39.52%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39880](http://purl.obolibrary.org/obo/NCIT_C39880) (Acinar Prostate Adenocarcinoma, Atrophic Variant))) 39.52%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39875](http://purl.obolibrary.org/obo/NCIT_C39875) (Loss of Chromosome 9q))) 39.52%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39874](http://purl.obolibrary.org/obo/NCIT_C39874) (Urethral Verrucous Carcinoma))) 39.52%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39873](http://purl.obolibrary.org/obo/NCIT_C39873) (Urethral Glandular Metaplasia))) 39.52%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39872](http://purl.obolibrary.org/obo/NCIT_C39872) (Urethral Villous Adenoma))) 39.52%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39866](http://purl.obolibrary.org/obo/NCIT_C39866) (Female Urethral Malignant Neoplasm))) 39.52%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39864](http://purl.obolibrary.org/obo/NCIT_C39864) (Carcinoma of Cowper Glands))) 39.52%


